BBH Holdings
VanEck Biotech ETF
1W: -3.3%
1M: -2.2%
3M: +12.8%
YTD: +24.8%
1Y: +37.9%
3Y: +54.0%
5Y: +12.7%
$237.45
-1.28 (-0.54%)
Weekly Expected Move ±3.2%
$222
$230
$237
$245
$253
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$457M
Holdings25
Top 10 Wt72.7%
Beta0.56
% Profitable65%
Coverage100%
Portfolio Valuation
P/E40.0
P/B9.5
P/S6.5
EV/EBITDA26.1
P/FCF21.9
PEG5.67
Profitability & Returns
Gross Margin73.6%
Net Margin10.9%
ROE16.2%
ROA5.1%
ROIC11.6%
Div Yield0.78%
Leverage & Liquidity
Debt/Equity1.41
Debt/Assets0.44
Net Debt/EBITDA2.2x
Interest Cov4.3x
Current Ratio1.67
Quick Ratio1.43
Growth (YoY)
Revenue+25.2%
Net Income+8.1%
EPS+9.4%
FCF+30.6%
EBITDA+4.3%
Rev CAGR 3Y+25.2%
Quality Scores
Piotroski F5.7
Altman Z7.77
IS Quality62.9
IS Overall58.6
IS Value39.8
Median P/E20.3
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 25 | 100.2% | 0.2 |
| Other | 1 | -0.3% | — |
Smart Money Overlap
0 holdings with signalsNo holdings with active convergence signals
Showing 26 of 26 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Amgen Inc | AMGN | 15.78% | $77.4M | 182,681 | 24.8 | $217.5B | Healthcare |
| 2 | Gilead Sciences Inc | GILD | 13.31% | $65.3M | 431,490 | -55.7 | $179.5B | Healthcare |
| 3 | Vertex Pharmaceuticals Inc | VRTX | 8.24% | $40.4M | 76,697 | 29.1 | $128.1B | Healthcare |
| 4 | Regeneron Pharmaceuticals Inc | REGN | 6.40% | $31.4M | 41,826 | 17.6 | $75.7B | Healthcare |
| 5 | Moderna Inc | MRNA | 6.37% | $31.3M | 153,623 | -23.8 | $75.4B | Healthcare |
| 6 | Natera Inc | NTRA | 5.33% | $26.1M | 63,071 | -301.7 | $58.8B | Healthcare |
| 7 | Argenx Se | ARGX | 4.62% | $22.7M | 23,348 | 33.3 | $57.2B | Healthcare |
| 8 | Iqvia Holdings Inc | IQV | 4.45% | $21.8M | 81,068 | 31.8 | $42.5B | Healthcare |
| 9 | Revolution Medicines Inc | RVMD | 4.18% | $20.5M | 100,312 | -23.3 | $43.9B | Healthcare |
| 10 | Illumina Inc | ILMN | 4.00% | $19.6M | 72,103 | 50.5 | $41.3B | Healthcare |
| 11 | Guardant Health Inc | GH | 2.98% | $14.6M | 82,250 | -50.9 | $23.9B | Healthcare |
| 12 | Alnylam Pharmaceuticals Inc | ALNY | 2.77% | $13.6M | 53,404 | 36.0 | $29.4B | Healthcare |
| 13 | Beone Medicines Ltd | ONC | 2.74% | $13.4M | 36,774 | 26.4 | $38.3B | Healthcare |
| 14 | Biogen Inc | BIIB | 2.73% | $13.4M | 58,969 | 38.7 | $32.5B | Healthcare |
| 15 | Incyte Corp | INCY | 2.25% | $11.0M | 89,566 | 14.2 | $23.4B | Healthcare |
| 16 | Insmed Inc | INSM | 2.13% | $10.4M | 90,270 | -27.0 | $24.1B | Healthcare |
| 17 | United Therapeutics Corp | UTHR | 1.98% | $9.7M | 20,174 | 17.9 | $23.0B | Healthcare |
| 18 | Biontech Se | BNTX | 1.58% | $7.8M | 78,773 | -12.7 | $24.3B | Healthcare |
| 19 | Charles River Laboratories Internationa | CRL | 1.50% | $7.4M | 24,837 | -60.0 | $14.0B | Healthcare |
| 20 | Neurocrine Biosciences Inc | NBIX | 1.35% | $6.6M | 47,813 | 20.3 | $14.4B | Healthcare |
| 21 | Icon Plc | ICLR | 1.24% | $6.1M | 35,741 | 37.8 | $12.4B | Healthcare |
| 22 | Bio-Techne Corp | TECH | 1.15% | $5.7M | 78,234 | 61.9 | $11.3B | Healthcare |
| 23 | Tempus Ai Inc | TEM | 1.12% | $5.5M | 66,250 | -53.6 | $13.4B | Healthcare |
| 24 | Biomarin Pharmaceutical Inc | BMRN | 1.11% | $5.5M | 91,052 | 150.5 | $11.1B | Healthcare |
| 25 | Qiagen Nv | QGEN | 0.93% | $4.6M | 103,170 | 22.9 | $9.2B | Healthcare |
| 26 | Other/Cash Cash | — | -0.26% | $-1,268,275 | — | — | — | — |